Jordan earned his Ph.D. in pharmaceutical sciences from the University of Tennessee Health Science Center in Memphis. His work led to the discovery of new pharmacological agents for the treatment of diabetic and age-related eye disease. He then spent over a year at the MD Anderson Cancer Research Center as a post-doctoral fellow to pursue a deeper understanding of how brain neuroglia coordinate the formation and regulation of the blood-brain barrier. These research activities generated numerous publications and two issued patents. Away from the laboratory, he is outdoors often running, biking and/or taking in the scenery. His down time consists of reading about seemingly random topics and appreciating music.
Are you Recursion ready?
Join our passionate, innovative team—and help us realize our goal of 100 treatments by 2025.